HEADER    HYDROLASE                               14-NOV-11   4A7I              
TITLE     FACTOR XA IN COMPLEX WITH A POTENT 2-AMINO-ETHANE SULFONAMIDE         
TITLE    2 INHIBITOR                                                            
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: FACTOR X LIGHT CHAIN;                                      
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: DES-GLA FACTOR X LIGHT CHAIN, RESIDUES 84-179;             
COMPND   5 SYNONYM: FACTOR XA, COAGULATION FACTOR X, STUART FACTOR, STUART-     
COMPND   6 PROWER FACTOR;                                                       
COMPND   7 EC: 3.4.21.6;                                                        
COMPND   8 OTHER_DETAILS: MADE DES-GLA BY CHYMOTRYPSIN CLEAVAGE;                
COMPND   9 MOL_ID: 2;                                                           
COMPND  10 MOLECULE: ACTIVATED FACTOR XA HEAVY CHAIN XA;                        
COMPND  11 CHAIN: B;                                                            
COMPND  12 FRAGMENT: ACTIVATED FACTOR X HEAVY CHAIN, RESIDUES 235-488;          
COMPND  13 SYNONYM: FACTOR XA, COAGULATION FACTOR X, STUART FACTOR, STUART-     
COMPND  14 PROWER FACTOR;                                                       
COMPND  15 EC: 3.4.21.6                                                         
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 TISSUE: BLOOD;                                                       
SOURCE   6 MOL_ID: 2;                                                           
SOURCE   7 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   8 ORGANISM_COMMON: HUMAN;                                              
SOURCE   9 ORGANISM_TAXID: 9606;                                                
SOURCE  10 TISSUE: BLOOD                                                        
KEYWDS    BLOOD COAGULATION FACTOR, CALCIUM- BINDING, EGF-LIKE DOMAIN, GAMMA-   
KEYWDS   2 CARBOXYGLUTAMIC ACID, GLYCOPROTEIN, HYDROLASE, HYDROXYLATION, SERINE 
KEYWDS   3 PROTEINASE, SERINE PROTEASE                                          
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    M.NAZARE,H.MATTER,D.W.WILL,M.WAGNER,M.URMANN,J.CZECH,H.SCHREUDER,     
AUTHOR   2 A.BAUER,K.RITTER,V.WEHNER                                            
REVDAT   3   09-OCT-24 4A7I    1       REMARK                                   
REVDAT   2   01-MAY-24 4A7I    1       REMARK LINK                              
REVDAT   1   01-FEB-12 4A7I    0                                                
JRNL        AUTH   M.NAZARE,H.MATTER,D.W.WILL,M.WAGNER,M.URMANN,J.CZECH,        
JRNL        AUTH 2 H.SCHREUDER,A.BAUER,K.RITTER,V.WEHNER                        
JRNL        TITL   FRAGMENT DECONSTRUCTION OF SMALL, POTENT FACTOR XA           
JRNL        TITL 2 INHIBITORS: EXPLORING THE SUPERADDITIVITY ENERGETICS OF      
JRNL        TITL 3 FRAGMENT LINKING IN PROTEIN-LIGAND COMPLEXES.                
JRNL        REF    ANGEW.CHEM.INT.ED.ENGL.       V.  51   905 2012              
JRNL        REFN                   ISSN 1433-7851                               
JRNL        PMID   22190348                                                     
JRNL        DOI    10.1002/ANIE.201107091                                       
REMARK   2                                                                      
REMARK   2 RESOLUTION.    2.40 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CNS 2002                                             
REMARK   3   AUTHORS     : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-              
REMARK   3               : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,              
REMARK   3               : READ,RICE,SIMONSON,WARREN                            
REMARK   3                                                                      
REMARK   3  REFINEMENT TARGET : MAXIMUM LIKELYHOOD                              
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 200.00                         
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   DATA CUTOFF HIGH         (ABS(F)) : 10000.000                      
REMARK   3   DATA CUTOFF LOW          (ABS(F)) : 0.0000                         
REMARK   3   COMPLETENESS (WORKING+TEST)   (%) : 99.1                           
REMARK   3   NUMBER OF REFLECTIONS             : 12692                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE            (WORKING SET) : 0.198                           
REMARK   3   FREE R VALUE                     : 0.253                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 4.800                           
REMARK   3   FREE R VALUE TEST SET COUNT      : 618                             
REMARK   3   ESTIMATED ERROR OF FREE R VALUE  : NULL                            
REMARK   3                                                                      
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
REMARK   3   TOTAL NUMBER OF BINS USED           : NULL                         
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : NULL                         
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : NULL                         
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : NULL                         
REMARK   3   REFLECTIONS IN BIN    (WORKING SET) : NULL                         
REMARK   3   BIN R VALUE           (WORKING SET) : NULL                         
REMARK   3   BIN FREE R VALUE                    : NULL                         
REMARK   3   BIN FREE R VALUE TEST SET SIZE  (%) : NULL                         
REMARK   3   BIN FREE R VALUE TEST SET COUNT     : NULL                         
REMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE : NULL                         
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 2247                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 25                                      
REMARK   3   SOLVENT ATOMS            : 206                                     
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 45.90                          
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 46.30                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : 0.10200                                              
REMARK   3    B22 (A**2) : 0.27600                                              
REMARK   3    B33 (A**2) : -0.37800                                             
REMARK   3    B12 (A**2) : 0.00000                                              
REMARK   3    B13 (A**2) : 0.00000                                              
REMARK   3    B23 (A**2) : 0.00000                                              
REMARK   3                                                                      
REMARK   3  ESTIMATED COORDINATE ERROR.                                         
REMARK   3   ESD FROM LUZZATI PLOT        (A) : NULL                            
REMARK   3   ESD FROM SIGMAA              (A) : NULL                            
REMARK   3   LOW RESOLUTION CUTOFF        (A) : NULL                            
REMARK   3                                                                      
REMARK   3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.                         
REMARK   3   ESD FROM C-V LUZZATI PLOT    (A) : NULL                            
REMARK   3   ESD FROM C-V SIGMAA          (A) : NULL                            
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.                                   
REMARK   3   BOND LENGTHS                 (A) : 0.005                           
REMARK   3   BOND ANGLES            (DEGREES) : 1.323                           
REMARK   3   DIHEDRAL ANGLES        (DEGREES) : NULL                            
REMARK   3   IMPROPER ANGLES        (DEGREES) : NULL                            
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL MODEL : RESTRAINED                                
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA                
REMARK   3   MAIN-CHAIN BOND              (A**2) : 1.757 ; 1.500                
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : 2.316 ; 2.000                
REMARK   3   SIDE-CHAIN BOND              (A**2) : 3.021 ; 2.000                
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : 3.571 ; 2.500                
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED : MASK                                                 
REMARK   3   KSOL        : 0.37                                                 
REMARK   3   BSOL        : 51.44                                                
REMARK   3                                                                      
REMARK   3  NCS MODEL : NULL                                                    
REMARK   3                                                                      
REMARK   3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT          
REMARK   3   GROUP  1  POSITIONAL            (A) : NULL  ; NULL                 
REMARK   3   GROUP  1  B-FACTOR           (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  PARAMETER FILE  1  : PROTEIN_REP.PARAM                              
REMARK   3  PARAMETER FILE  2  : ION.PARAM                                      
REMARK   3  PARAMETER FILE  3  : WATER_REP.PARAM                                
REMARK   3  PARAMETER FILE  4  : A23.PAR                                        
REMARK   3  PARAMETER FILE  5  : NULL                                           
REMARK   3  TOPOLOGY FILE  1   : PROTEIN.TOP                                    
REMARK   3  TOPOLOGY FILE  2   : ION.TOP                                        
REMARK   3  TOPOLOGY FILE  3   : WATER.TOP                                      
REMARK   3  TOPOLOGY FILE  4   : A23.PAR                                        
REMARK   3  TOPOLOGY FILE  5   : NULL                                           
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: DISORDERED SIDE CHAINS WERE MODELED       
REMARK   3  STEREOCHEMICALLY.                                                   
REMARK   4                                                                      
REMARK   4 4A7I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-NOV-11.                  
REMARK 100 THE DEPOSITION ID IS D_1290050306.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 02-MAY-05                          
REMARK 200  TEMPERATURE           (KELVIN) : 100.0                              
REMARK 200  PH                             : 5.7                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : ESRF                               
REMARK 200  BEAMLINE                       : ID14-3                             
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.931                              
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : ADSC QUANTUM 4R                    
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : XDS                                
REMARK 200  DATA SCALING SOFTWARE          : XSCALE                             
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 12692                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 2.400                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 19.660                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : -3.000                             
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 99.0                               
REMARK 200  DATA REDUNDANCY                : 3.600                              
REMARK 200  R MERGE                    (I) : 0.04000                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 21.0000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 2.48                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 100.0                              
REMARK 200  DATA REDUNDANCY IN SHELL       : 3.50                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.20000                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 6.000                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: CNX RIGID BODY REFINEMENT                             
REMARK 200 STARTING MODEL: UNPUBLISHED FACTOR XA STRUCTURE                      
REMARK 200                                                                      
REMARK 200 REMARK: NONE                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 49.70                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION: 8 MG/ML PROTEIN, 5     
REMARK 280  MM MES (PH 5.7), 5 MM CACL2, 100 MM BENZAMIDINE. RESERVOIR: 18-     
REMARK 280  20% PEG-600, 50 MM MES (PH 5.7). SOAKING: ADD 10 MM INHIBITOR.      
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21                       
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X+1/2,-Y,Z+1/2                                         
REMARK 290       3555   -X,Y+1/2,-Z+1/2                                         
REMARK 290       4555   X+1/2,-Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000       28.12650            
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       38.70800            
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       36.02100            
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000       38.70800            
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       28.12650            
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000       36.02100            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC                           
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 1830 ANGSTROM**2                          
REMARK 350 SURFACE AREA OF THE COMPLEX: 13220 ANGSTROM**2                       
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.7 KCAL/MOL                        
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 465                                                                      
REMARK 465 MISSING RESIDUES                                                     
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
REMARK 465                                                                      
REMARK 465   M RES C SSSEQI                                                     
REMARK 465     TYR A   -41                                                      
REMARK 465     LYS A   -40                                                      
REMARK 465     ASP A   -39                                                      
REMARK 465     GLY A   -38                                                      
REMARK 465     ASP A   -37                                                      
REMARK 465     GLN A   -36                                                      
REMARK 465     CYS A   -35                                                      
REMARK 465     GLU A   -34                                                      
REMARK 465     THR A   -33                                                      
REMARK 465     SER A   -32                                                      
REMARK 465     PRO A   -31                                                      
REMARK 465     CYS A   -30                                                      
REMARK 465     GLN A   -29                                                      
REMARK 465     ASN A   -28                                                      
REMARK 465     GLN A   -27                                                      
REMARK 465     GLY A   -26                                                      
REMARK 465     LYS A   -25                                                      
REMARK 465     CYS A   -24                                                      
REMARK 465     LYS A   -23                                                      
REMARK 465     ASP A   -22                                                      
REMARK 465     GLY A   -21                                                      
REMARK 465     LEU A   -20                                                      
REMARK 465     GLY A   -19                                                      
REMARK 465     GLU A   -18                                                      
REMARK 465     TYR A   -17                                                      
REMARK 465     THR A   -16                                                      
REMARK 465     CYS A   -15                                                      
REMARK 465     THR A   -14                                                      
REMARK 465     CYS A   -13                                                      
REMARK 465     LEU A   -12                                                      
REMARK 465     GLU A   -11                                                      
REMARK 465     GLY A   -10                                                      
REMARK 465     PHE A    -9                                                      
REMARK 465     GLU A    -8                                                      
REMARK 465     GLY A    -7                                                      
REMARK 465     LYS A    -6                                                      
REMARK 465     ASN A    -5                                                      
REMARK 465     CYS A    -4                                                      
REMARK 465     GLU A    -3                                                      
REMARK 465     LEU A    -2                                                      
REMARK 465     PHE A    -1                                                      
REMARK 465     THR A     0                                                      
REMARK 465     ARG A    51                                                      
REMARK 465     ARG B   245                                                      
REMARK 465     GLY B   246                                                      
REMARK 465     LEU B   247                                                      
REMARK 465     PRO B   248                                                      
REMARK 465     LYS B   249                                                      
REMARK 465     ALA B   250                                                      
REMARK 465     LYS B   251                                                      
REMARK 465     SER B   252                                                      
REMARK 465     HIS B   253                                                      
REMARK 465     ALA B   254                                                      
REMARK 465     PRO B   255                                                      
REMARK 465     GLU B   256                                                      
REMARK 465     VAL B   257                                                      
REMARK 465     ILE B   258                                                      
REMARK 465     THR B   259                                                      
REMARK 465     SER B   260                                                      
REMARK 465     SER B   261                                                      
REMARK 465     PRO B   262                                                      
REMARK 465     LEU B   263                                                      
REMARK 465     LYS B   264                                                      
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    LEU A   1C    -131.06     51.75                                   
REMARK 500    ASN A   5       25.95     48.91                                   
REMARK 500    GLN A  10     -109.88   -126.95                                   
REMARK 500    ASN A  17     -175.14     72.06                                   
REMARK 500    SER A  18     -175.17     57.33                                   
REMARK 500    LYS A  34      -53.90   -133.94                                   
REMARK 500    GLN B  75     -158.54   -152.75                                   
REMARK 500    GLU B  76       83.63   -154.53                                   
REMARK 500    ARG B 115     -169.48   -173.28                                   
REMARK 500    SER B 214      -67.72   -105.97                                   
REMARK 500    ALA B 221       17.13     55.56                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 620                                                                      
REMARK 620 METAL COORDINATION                                                   
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):                             
REMARK 620                                                                      
REMARK 620 COORDINATION ANGLES FOR:  M RES CSSEQI METAL                         
REMARK 620                              CA B1245  CA                            
REMARK 620 N RES CSSEQI ATOM                                                    
REMARK 620 1 ASP B  70   OD1                                                    
REMARK 620 2 ASN B  72   O    72.0                                              
REMARK 620 3 GLU B  80   OE2  84.6 152.3                                        
REMARK 620 4 HOH B2037   O    73.4  98.8  59.3                                  
REMARK 620 5 HOH B2038   O    72.2  67.5 119.8 145.5                            
REMARK 620 N                    1     2     3     4                             
REMARK 700                                                                      
REMARK 700 SHEET                                                                
REMARK 700 DETERMINATION METHOD: DSSP                                           
REMARK 700 THE SHEETS PRESENTED AS "BB" IN EACH CHAIN ON SHEET RECORDS          
REMARK 700 BELOW IS ACTUALLY AN  6-STRANDED BARREL THIS IS REPRESENTED BY       
REMARK 700 A  7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS              
REMARK 700 ARE IDENTICAL.                                                       
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B 1245                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A7I B 1246                
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1WU1   RELATED DB: PDB                                   
REMARK 900 FACTOR XA IN COMPLEX WITH THE INHIBITOR 4-[(5- CHLOROINDOL-2-YL)     
REMARK 900 SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-( PYRIDIN-4-YL)PYRIMIDIN-2-YL]    
REMARK 900 CARBONYL]PIPERAZINE                                                  
REMARK 900 RELATED ID: 2J34   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX             
REMARK 900 RELATED ID: 2BQ7   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43                    
REMARK 900 RELATED ID: 2Y5G   RELATED DB: PDB                                   
REMARK 900 FACTOR XA - CATION INHIBITOR COMPLEX                                 
REMARK 900 RELATED ID: 2W3K   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4- DISUBSTITUTED          
REMARK 900 PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 1                            
REMARK 900 RELATED ID: 2VWO   RELATED DB: PDB                                   
REMARK 900 AMINOPYRROLIDINE FACTOR XA INHIBITOR                                 
REMARK 900 RELATED ID: 1XKA   RELATED DB: PDB                                   
REMARK 900 FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX- 2212A,(2S) -(3'-  
REMARK 900 AMIDINO-3-BIPHENYLYL)-5-(4- PYRIDYLAMINO)PENTANOIC ACID              
REMARK 900 RELATED ID: 1NFW   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH       
REMARK 900 RPR209685                                                            
REMARK 900 RELATED ID: 2GD4   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-               
REMARK 900 PENTASACCHARIDE COMPLEX                                              
REMARK 900 RELATED ID: 2VVV   RELATED DB: PDB                                   
REMARK 900 AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR                
REMARK 900 RELATED ID: 2Y5F   RELATED DB: PDB                                   
REMARK 900 FACTOR XA - CATION INHIBITOR COMPLEX                                 
REMARK 900 RELATED ID: 2XBX   RELATED DB: PDB                                   
REMARK 900 FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID       
REMARK 900 INHIBITOR                                                            
REMARK 900 RELATED ID: 1MSX   RELATED DB: PDB                                   
REMARK 900 HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N-AMINO-15N- IMINO-13C-       
REMARK 900 METHYL)PHENOXY]-6-[3-(15N-AMINO-13C-METHYL )PHENOXY]-3,5-DIFLUORO-4- 
REMARK 900 METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND   
REMARK 900 MD SIMULATIONS.                                                      
REMARK 900 RELATED ID: 1LPG   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79.                         
REMARK 900 RELATED ID: 2VVU   RELATED DB: PDB                                   
REMARK 900 AMINOPYRROLIDINE FACTOR XA INHIBITOR                                 
REMARK 900 RELATED ID: 1P0S   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH      
REMARK 900 ECOTIN M84R                                                          
REMARK 900 RELATED ID: 2G00   RELATED DB: PDB                                   
REMARK 900 FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-(6-(2'-(( DIMETHYLAMINO)   
REMARK 900 METHYL)-4-BIPHENYLYL)-7-OXO-3-( TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO- 
REMARK 900 1H-PYRAZOLO[3,4 -C]PYRIDIN-1-YL)BENZAMIDE                            
REMARK 900 RELATED ID: 1MQ6   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(5- CHLORO-2-          
REMARK 900 PYRIDINYL)AMINO]CARBONYL]-6-METHOXYPHENYL]-4 -[[(4,5-DIHYDRO-2-      
REMARK 900 OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH  
REMARK 900 HUMAN FACTOR XA                                                      
REMARK 900 RELATED ID: 1XKB   RELATED DB: PDB                                   
REMARK 900 FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX- 2212A,(2S) -(3'-  
REMARK 900 AMIDINO-3-BIPHENYLYL)-5-(4- PYRIDYLAMINO)PENTANOIC ACID              
REMARK 900 RELATED ID: 1IQE   RELATED DB: PDB                                   
REMARK 900 HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590                     
REMARK 900 RELATED ID: 1G2M   RELATED DB: PDB                                   
REMARK 900 FACTOR XA INHIBITOR COMPLEX                                          
REMARK 900 RELATED ID: 2VH0   RELATED DB: PDB                                   
REMARK 900 STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL   
REMARK 900 PYRROLIDIN-2-ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS            
REMARK 900 RELATED ID: 1NFY   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH       
REMARK 900 RPR200095                                                            
REMARK 900 RELATED ID: 2UWL   RELATED DB: PDB                                   
REMARK 900 SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND   
REMARK 900 FACTOR XA                                                            
REMARK 900 RELATED ID: 2BOK   RELATED DB: PDB                                   
REMARK 900 FACTOR XA - CATION                                                   
REMARK 900 RELATED ID: 1HCG   RELATED DB: PDB                                   
REMARK 900 BLOOD COAGULATION FACTOR XA                                          
REMARK 900 RELATED ID: 1LPZ   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41.                         
REMARK 900 RELATED ID: 2W3I   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4- DISUBSTITUTED          
REMARK 900 PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 2                            
REMARK 900 RELATED ID: 2JKH   RELATED DB: PDB                                   
REMARK 900 FACTOR XA - CATION INHIBITOR COMPLEX                                 
REMARK 900 RELATED ID: 1Z6E   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN                
REMARK 900 RELATED ID: 2UWP   RELATED DB: PDB                                   
REMARK 900 FACTOR XA INHIBITOR COMPLEX                                          
REMARK 900 RELATED ID: 2XC4   RELATED DB: PDB                                   
REMARK 900 FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID       
REMARK 900 INHIBITOR                                                            
REMARK 900 RELATED ID: 2Y81   RELATED DB: PDB                                   
REMARK 900 STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:         
REMARK 900 PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS   
REMARK 900 RELATED ID: 1G2L   RELATED DB: PDB                                   
REMARK 900 FACTOR XA INHIBITOR COMPLEX                                          
REMARK 900 RELATED ID: 1NFU   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH       
REMARK 900 RPR132747                                                            
REMARK 900 RELATED ID: 2XC0   RELATED DB: PDB                                   
REMARK 900 FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID       
REMARK 900 INHIBITOR                                                            
REMARK 900 RELATED ID: 2BQ6   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21                    
REMARK 900 RELATED ID: 1FAX   RELATED DB: PDB                                   
REMARK 900 COAGULATION FACTOR XA INHIBITOR COMPLEX                              
REMARK 900 RELATED ID: 1IQF   RELATED DB: PDB                                   
REMARK 900 HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165                     
REMARK 900 RELATED ID: 2Y7X   RELATED DB: PDB                                   
REMARK 900 THE DISCOVERY OF POTENT AND LONG-ACTING ORAL FACTOR XA INHIBITORS    
REMARK 900 WITH TETRAHYDROISOQUINOLINE AND BENZAZEPINE P4 MOTIFS                
REMARK 900 RELATED ID: 1NL8   RELATED DB: PDB                                   
REMARK 900 THEORETICAL MODEL OF THE TISSUE FACTOR/FACTOR VIIA/ FACTORXA COMPLEX 
REMARK 900 RELATED ID: 1IQG   RELATED DB: PDB                                   
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159                    
REMARK 900 RELATED ID: 1IQH   RELATED DB: PDB                                   
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143                    
REMARK 900 RELATED ID: 1LQD   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45.                         
REMARK 900 RELATED ID: 2UWO   RELATED DB: PDB                                   
REMARK 900 SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND   
REMARK 900 FACTOR XA                                                            
REMARK 900 RELATED ID: 1C5M   RELATED DB: PDB                                   
REMARK 900 STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING,    
REMARK 900 SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR    
REMARK 900 RELATED ID: 1IOE   RELATED DB: PDB                                   
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532                    
REMARK 900 RELATED ID: 1F0S   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH      
REMARK 900 RPR208707                                                            
REMARK 900 RELATED ID: 1F0R   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH      
REMARK 900 RPR208815                                                            
REMARK 900 RELATED ID: 2XBY   RELATED DB: PDB                                   
REMARK 900 FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID       
REMARK 900 INHIBITOR                                                            
REMARK 900 RELATED ID: 2XC5   RELATED DB: PDB                                   
REMARK 900 FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID       
REMARK 900 INHIBITOR                                                            
REMARK 900 RELATED ID: 2Y7Z   RELATED DB: PDB                                   
REMARK 900 STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:         
REMARK 900 PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS   
REMARK 900 RELATED ID: 1MQ5   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(4- CHLOROPHENYL)      
REMARK 900 AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1- PIPERAZINYL)METHYL]-2-        
REMARK 900 THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA                   
REMARK 900 RELATED ID: 2BMG   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50                    
REMARK 900 RELATED ID: 1IQN   RELATED DB: PDB                                   
REMARK 900 HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192                     
REMARK 900 RELATED ID: 2XBV   RELATED DB: PDB                                   
REMARK 900 FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID       
REMARK 900 INHIBITOR                                                            
REMARK 900 RELATED ID: 2BQW   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45           
REMARK 900 RELATED ID: 1IQM   RELATED DB: PDB                                   
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471                    
REMARK 900 RELATED ID: 1EZQ   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH      
REMARK 900 RPR128515                                                            
REMARK 900 RELATED ID: 2VWL   RELATED DB: PDB                                   
REMARK 900 AMINOPYRROLIDINE FACTOR XA INHIBITOR                                 
REMARK 900 RELATED ID: 2VH6   RELATED DB: PDB                                   
REMARK 900 STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:         
REMARK 900 PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS                              
REMARK 900 RELATED ID: 1FJS   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031 )COMPLEXED     
REMARK 900 WITH FACTOR XA                                                       
REMARK 900 RELATED ID: 1LPK   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125.                        
REMARK 900 RELATED ID: 2J4I   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX             
REMARK 900 RELATED ID: 2Y5H   RELATED DB: PDB                                   
REMARK 900 FACTOR XA - CATION INHIBITOR COMPLEX                                 
REMARK 900 RELATED ID: 1NFX   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH       
REMARK 900 RPR208944                                                            
REMARK 900 RELATED ID: 2VWN   RELATED DB: PDB                                   
REMARK 900 AMINOPYRROLIDINE FACTOR XA INHIBITOR                                 
REMARK 900 RELATED ID: 1IQJ   RELATED DB: PDB                                   
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124                    
REMARK 900 RELATED ID: 2J94   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX             
REMARK 900 RELATED ID: 2J95   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX             
REMARK 900 RELATED ID: 2CJI   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX             
REMARK 900 RELATED ID: 2BOH   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1                     
REMARK 900 RELATED ID: 2J38   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX             
REMARK 900 RELATED ID: 2VVC   RELATED DB: PDB                                   
REMARK 900 AMINOPYRROLIDINE FACTOR XA INHIBITOR                                 
REMARK 900 RELATED ID: 2W26   RELATED DB: PDB                                   
REMARK 900 FATOR XA IN COMPLEX WITH BAY59-7939                                  
REMARK 900 RELATED ID: 1IQI   RELATED DB: PDB                                   
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125                    
REMARK 900 RELATED ID: 2VWM   RELATED DB: PDB                                   
REMARK 900 AMINOPYRROLIDINE FACTOR XA INHIBITOR                                 
REMARK 900 RELATED ID: 1KYE   RELATED DB: PDB                                   
REMARK 900 FACTOR XA IN COMPLEX WITH (R)-2-(3-ADAMANTAN-1-YL -UREIDO)-3-(3-     
REMARK 900 CARBAMIMIDOYL-PHENYL)-N-PHENETHYL- PROPIONAMIDE                      
REMARK 900 RELATED ID: 2Y82   RELATED DB: PDB                                   
REMARK 900 STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:         
REMARK 900 PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS   
REMARK 900 RELATED ID: 2Y80   RELATED DB: PDB                                   
REMARK 900 STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:         
REMARK 900 PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS   
REMARK 900 RELATED ID: 1IQK   RELATED DB: PDB                                   
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113                    
REMARK 900 RELATED ID: 2WYJ   RELATED DB: PDB                                   
REMARK 900 STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:         
REMARK 900 PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS                            
REMARK 900 RELATED ID: 1V3X   RELATED DB: PDB                                   
REMARK 900 FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-[6-METHYL -4,5,6,7-        
REMARK 900 TETRAHYDROTHIAZOLO(5,4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4-(6-    
REMARK 900 CHLORONAPHTH-2-YLSULPHONYL) PIPERAZINE                               
REMARK 900 RELATED ID: 2FZZ   RELATED DB: PDB                                   
REMARK 900 FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3-AMINO- 1,2-             
REMARK 900 BENZISOXAZOL-5-YL)-6-(2'-(((3R)-3-HYDROXY-1- PYRROLIDINYL)METHYL)-4- 
REMARK 900 BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1, 4,5,6-TETRAHYDRO-7H-PYRAZOLO[3,4- 
REMARK 900 C]PYRIDIN-7-ONE                                                      
REMARK 900 RELATED ID: 2J2U   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX             
REMARK 900 RELATED ID: 2XBW   RELATED DB: PDB                                   
REMARK 900 FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4- DICARBOXYLIC ACID       
REMARK 900 INHIBITOR                                                            
REMARK 900 RELATED ID: 2WYG   RELATED DB: PDB                                   
REMARK 900 STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:         
REMARK 900 PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS                            
REMARK 900 RELATED ID: 1KSN   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH       
REMARK 900 FXV673                                                               
REMARK 900 RELATED ID: 1IQL   RELATED DB: PDB                                   
REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476                    
DBREF  4A7I A  -41    51  UNP    P00742   FA10_HUMAN      84    179             
DBREF  4A7I B   16   264  UNP    P00742   FA10_HUMAN     235    488             
SEQRES   1 A   96  TYR LYS ASP GLY ASP GLN CYS GLU THR SER PRO CYS GLN          
SEQRES   2 A   96  ASN GLN GLY LYS CYS LYS ASP GLY LEU GLY GLU TYR THR          
SEQRES   3 A   96  CYS THR CYS LEU GLU GLY PHE GLU GLY LYS ASN CYS GLU          
SEQRES   4 A   96  LEU PHE THR ARG LYS LEU CYS SER LEU ASP ASN GLY ASP          
SEQRES   5 A   96  CYS ASP GLN PHE CYS HIS GLU GLU GLN ASN SER VAL VAL          
SEQRES   6 A   96  CYS SER CYS ALA ARG GLY TYR THR LEU ALA ASP ASN GLY          
SEQRES   7 A   96  LYS ALA CYS ILE PRO THR GLY PRO TYR PRO CYS GLY LYS          
SEQRES   8 A   96  GLN THR LEU GLU ARG                                          
SEQRES   1 B  254  ILE VAL GLY GLY GLN GLU CYS LYS ASP GLY GLU CYS PRO          
SEQRES   2 B  254  TRP GLN ALA LEU LEU ILE ASN GLU GLU ASN GLU GLY PHE          
SEQRES   3 B  254  CYS GLY GLY THR ILE LEU SER GLU PHE TYR ILE LEU THR          
SEQRES   4 B  254  ALA ALA HIS CYS LEU TYR GLN ALA LYS ARG PHE LYS VAL          
SEQRES   5 B  254  ARG VAL GLY ASP ARG ASN THR GLU GLN GLU GLU GLY GLY          
SEQRES   6 B  254  GLU ALA VAL HIS GLU VAL GLU VAL VAL ILE LYS HIS ASN          
SEQRES   7 B  254  ARG PHE THR LYS GLU THR TYR ASP PHE ASP ILE ALA VAL          
SEQRES   8 B  254  LEU ARG LEU LYS THR PRO ILE THR PHE ARG MET ASN VAL          
SEQRES   9 B  254  ALA PRO ALA CYS LEU PRO GLU ARG ASP TRP ALA GLU SER          
SEQRES  10 B  254  THR LEU MET THR GLN LYS THR GLY ILE VAL SER GLY PHE          
SEQRES  11 B  254  GLY ARG THR HIS GLU LYS GLY ARG GLN SER THR ARG LEU          
SEQRES  12 B  254  LYS MET LEU GLU VAL PRO TYR VAL ASP ARG ASN SER CYS          
SEQRES  13 B  254  LYS LEU SER SER SER PHE ILE ILE THR GLN ASN MET PHE          
SEQRES  14 B  254  CYS ALA GLY TYR ASP THR LYS GLN GLU ASP ALA CYS GLN          
SEQRES  15 B  254  GLY ASP SER GLY GLY PRO HIS VAL THR ARG PHE LYS ASP          
SEQRES  16 B  254  THR TYR PHE VAL THR GLY ILE VAL SER TRP GLY GLU GLY          
SEQRES  17 B  254  CYS ALA ARG LYS GLY LYS TYR GLY ILE TYR THR LYS VAL          
SEQRES  18 B  254  THR ALA PHE LEU LYS TRP ILE ASP ARG SER MET LYS THR          
SEQRES  19 B  254  ARG GLY LEU PRO LYS ALA LYS SER HIS ALA PRO GLU VAL          
SEQRES  20 B  254  ILE THR SER SER PRO LEU LYS                                  
HET     CA  B1245       1                                                       
HET    A7I  B1246      24                                                       
HETNAM      CA CALCIUM ION                                                      
HETNAM     A7I 5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID [2-(1--ISOPROPYL-           
HETNAM   2 A7I  PIPERIDIN-4-YLSULFAMOYL)-ETHYL]-AMIDE                           
FORMUL   3   CA    CA 2+                                                        
FORMUL   4  A7I    C15 H24 CL N3 O3 S2                                          
FORMUL   5  HOH   *206(H2 O)                                                    
HELIX    1   1 LYS A    1B LEU A    3  5                                   5    
HELIX    2   2 LEU A    3  CYS A    8  5                                   6    
HELIX    3   3 ALA B   56  GLN B   61  5                                   6    
HELIX    4   4 GLU B  124A LEU B  131A 1                                   9    
HELIX    5   5 ASP B  164  SER B  172  1                                   9    
HELIX    6   6 PHE B  234  THR B  244  1                                  11    
SHEET    1  AA 2 PHE A  11  HIS A  13  0                                        
SHEET    2  AA 2 VAL A  20  SER A  22 -1  O  VAL A  20   N  HIS A  13           
SHEET    1  AB 2 TYR A  27  LEU A  29  0                                        
SHEET    2  AB 2 CYS A  36  PRO A  38 -1  O  ILE A  37   N  THR A  28           
SHEET    1  BA 7 GLN B  20  GLU B  21  0                                        
SHEET    2  BA 7 LYS B 156  PRO B 161 -1  O  MET B 157   N  GLN B  20           
SHEET    3  BA 7 THR B 135  GLY B 140 -1  O  GLY B 136   N  VAL B 160           
SHEET    4  BA 7 PRO B 198  PHE B 203 -1  O  PRO B 198   N  SER B 139           
SHEET    5  BA 7 THR B 206  TRP B 215 -1  O  THR B 206   N  PHE B 203           
SHEET    6  BA 7 GLY B 226  LYS B 230 -1  O  ILE B 227   N  TRP B 215           
SHEET    7  BA 7 MET B 180  ALA B 183 -1  O  PHE B 181   N  TYR B 228           
SHEET    1  BB 7 GLN B  30  ILE B  34  0                                        
SHEET    2  BB 7 GLY B  40  ILE B  46 -1  N  PHE B  41   O  LEU B  33           
SHEET    3  BB 7 TYR B  51  THR B  54 -1  O  LEU B  53   N  THR B  45           
SHEET    4  BB 7 ALA B 104  LEU B 108 -1  O  ALA B 104   N  THR B  54           
SHEET    5  BB 7 ALA B  81  LYS B  90 -1  N  GLU B  86   O  ARG B 107           
SHEET    6  BB 7 LYS B  65  VAL B  68 -1  O  VAL B  66   N  HIS B  83           
SHEET    7  BB 7 GLN B  30  ILE B  34 -1  O  LEU B  32   N  ARG B  67           
SSBOND   1 CYS A    1    CYS A   12                          1555   1555  2.04  
SSBOND   2 CYS A    8    CYS A   21                          1555   1555  2.03  
SSBOND   3 CYS A   23    CYS A   36                          1555   1555  2.04  
SSBOND   4 CYS A   44    CYS B  122                          1555   1555  2.03  
SSBOND   5 CYS B   22    CYS B   27                          1555   1555  2.04  
SSBOND   6 CYS B   42    CYS B   58                          1555   1555  2.03  
SSBOND   7 CYS B  168    CYS B  182                          1555   1555  2.02  
SSBOND   8 CYS B  191    CYS B  220                          1555   1555  2.03  
LINK         OD1 ASP B  70                CA    CA B1245     1555   1555  2.75  
LINK         O   ASN B  72                CA    CA B1245     1555   1555  2.71  
LINK         OE2 GLU B  80                CA    CA B1245     1555   1555  3.06  
LINK        CA    CA B1245                 O   HOH B2037     1555   1555  2.95  
LINK        CA    CA B1245                 O   HOH B2038     1555   1555  2.85  
SITE     1 AC1  8 ASP B  70  ASN B  72  GLN B  75  GLU B  76                    
SITE     2 AC1  8 GLU B  77  GLU B  80  HOH B2037  HOH B2038                    
SITE     1 AC2 15 GLU B  97  TYR B  99  PHE B 174  ALA B 190                    
SITE     2 AC2 15 GLN B 192  VAL B 213  TRP B 215  GLY B 216                    
SITE     3 AC2 15 GLY B 219  CYS B 220  GLY B 226  ILE B 227                    
SITE     4 AC2 15 TYR B 228  HOH B2031  HOH B2122                               
CRYST1   56.253   72.042   77.416  90.00  90.00  90.00 P 21 21 21    4          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.017777  0.000000  0.000000        0.00000                         
SCALE2      0.000000  0.013881  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.012917        0.00000